265-275
Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services
Gethin L. Griffith, Rhiannon Tudor Edwards, J. Mark G. Williams, Jonathon Gray and Val Morrison, et al.
277-287
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting
Debra Morgan, Heather Sylvester, F. Lee Lucas and Susan Miesfeldt
289-298
Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing
Makia J. Marafie, Sadiqa Al-Awadi, Fatemah Al-Mosawi, Alaa Elshafey and Waleed Al-Ali, et al.
299-305
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer
Marijana Lijovic, Susan R. Davis, Pam Fradkin, Jo Bradbury and Maria La China, et al.
307-311
Genetic polymorphism in ornithine decarboxylase and risk of breast cancer
Iain Brown, Susan Halliday, Heather Greig, Steven D. Heys and Heather M. Wallace, et al.
313-323
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis
Michael D. Walsh, Daniel D. Buchanan, Rhiannon Walters, Aedan Roberts and Sven Arnold, et al.
325-337
Open AccessGenetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact
Karin M. Landsbergen, Judith B. Prins, Han G. Brunner, Floris W. Kraaimaat and Nicoline Hoogerbrugge
339-346
Methylation not a frequent “second hit” in tumors with germline BRCA mutations
Amy M. Dworkin, Andrew D. Spearman, Stephanie Y. Tseng, Kevin Sweet and Amanda Ewart Toland
347-353
PALB2 sequence variants in young South African breast cancer patients
Michelle Sluiter, Samantha Mew and Elizabeth J. van Rensburg
355-358
CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia
Eswary Thirthagiri, Leng San Cheong, Cheng Har Yip and Soo-Hwang Teo
359-362
First case report of Muir–Torre syndrome associated with non-small cell lung cancer
L. Nolan, D. Eccles, E. Cross, G. Crawford and N. Beck, et al.
363-369
Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals
Wendy McKinnon, Kimberly C. Banks, Joan Skelly, Wendy Kohlmann and Robin Bennett, et al.
371-377
Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes
Valérie Chaudru, M. T. Lo, F. Lesueur, C. Marian and H. Mohamdi, et al.
379-382
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation
Caterina Mian, Susi Barollo, Laura Zambonin, Gianmaria Pennelli and Paolo Bernante, et al.
383-390
TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
Carla Pinto, Isabel Veiga, Manuela Pinheiro, Ana Peixoto and Armando Pinto, et al.
391-397
Open AccessImprovement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
Lotte H. M. Gerritzen, Nicoline Hoogerbrugge, Angèle L. M. Oei, Fokko M. Nagengast and Maaike A. P. C. van Ham, et al.
399-402
The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women
Tal Distelman Menachem, Yael Laitman, Bella Kaufman and Eitan Friedman
403-412
Cancer genetic predisposition: information needs of patients irrespective of risk level
Alison Metcalfe, Julie Werrett, Lucy Burgess, Cyril Chapman and Collette Clifford
413-419
A high frequent BRCA1 founder mutation identified in the Greenlandic population
Theresa Larriba Harboe, Hans Eiberg, Peder Kern, Bent Ejlertsen and Lotte Nedergaard, et al.
421-429
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome
Gašper Berginc, Matej Bračko, Metka Ravnik-Glavač and Damjan Glavač
431-439
Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study
K. Elmasry, A. J. Davies, D. G. Evans, M. N. Seif and K. Reynolds
441-449
Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer
Gwendolyn P. Quinn, Susan T. Vadaparampil, Lindsey M. King, Cheryl A. Miree and Sue Friedman
451-456
Younger age-at-diagnosis for familial malignant testicular germ cell tumor
Phuong L. Mai, Bingshu E. Chen, Kathy Tucker, Michael Friedlander and Kelly-Anne Phillips, et al.
457-464
Open AccessAttitude towards pre-implantation genetic diagnosis for hereditary cancer
Chantal Lammens, Eveline Bleiker, Neil Aaronson, Annette Vriends and Margreet Ausems, et al.
465-471
Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease
Shirin Hasani-Ranjbar, Mahsa M. Amoli, Azadeh Ebrahim-Habibi, Vahid Haghpanah and Maryam Hejazi, et al.
473-478
Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations
Bella Kaufman, Yael Laitman, Jacek Gronwald, Robert Winqvist and Arvids Irmejs, et al.
479-482
Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer
Emma Edwards, Catharina Yearwood, Julie Sillibourne, Diana Baralle and Diana Eccles
483-487
Are prediction models for Lynch syndrome valid for probands with endometrial cancer?
Floor J. Backes, Heather Hampel, Katherine A. Backes, Luis Vaccarello and George Lewandowski, et al.
489-500
Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients
Lise Lotte Christensen, Reetta Kariola, Mari K. Korhonen, Friedrik P. Wikman and Lone Sunde, et al.
501-504
Open AccessEpitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome
Israel Zighelboim, Matthew A. Powell, Sheri A. Babb, Alison J. Whelan and Amy P. Schmidt, et al.
505-508
Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population
Moon-Woo Seong, Sung Im Cho, Dong-Young Noh, Wonshik Han and Sung-Won Kim, et al.
509-517
Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay
Hiromu Naruse, Noriko Ikawa, Kiyoshi Yamaguchi, Yusuke Nakamura and Masami Arai, et al.
519-523
Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation
D. A. Stupart, P. A. Goldberg, U. Algar and R. Ramesar
525-531
Association of MUTYH and MSH6 germline mutations in colorectal cancer patients
María Dolores Giráldez, Francesc Balaguer, Trinidad Caldés, Ana Sanchez-de-Abajo and Nuria Gómez-Fernández, et al.
533-539
A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations
Cristina Martínez-Bouzas, Elena Beristain, Enrique Ojembarrena, Jose Errasti and Karmele Mujika, et al.
541-546
p53 tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li–Fraumeni syndrome and a child with adrenocortical carcinoma
Lucja Fiszer-Maliszewska, Bernarda Kazanowska, Joanna Padzik and The Regional Blood Transfusion Center
547-553
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome
S. Gargiulo, M. Torrini, S. Ollila, S. Nasti and L. Pastorino, et al.
555-561
The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer
Helgi Birgisson, Arezo Ghanipour, Kennet Smedh, Lars Påhlman and Bengt Glimelius
563-567
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30
Ophira M. Ginsburg, Mohammad R. Akbari, Zeba Aziz, Robert Young and Henry Lynch, et al.
569-580
FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin
David E. Joyner, Sylvia H. Trang, Albert J. Aboulafia, Timothy A. Damron and R. Lor Randall
581-584
Molecular study of CEPBA in familial hematological malignancies
R. El Abed, V. Bourdon, L. Huiart, F. Eisinger and A. Khelif, et al.